Prolacta Bioscience Appoints Dr. Erin Hamilton Spence as Director of Clinical Education and Professional Development
Type: Press Releases
Topic(s): Company
Multiple peer-reviewed studies show Prolacta’s 100% human milk-based nutritional fortifiers reduce risk of life-threatening comorbidities in premature infants, compared to cow milk-based nutrition
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies Clinical Studies on Prolact/Humavant CR Company Growth Late-Onset Sepsis Necrotizing Entercolitis (NEC) Retinopathy of Prematurity (ROP)
Prolacta Bioscience introduces its first evidence-based feeding protocol for an exclusive human milk diet in the NICU
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD) Company Early Fortification Feeding Intolerance Feeding Protocols Growth Healthcare Professionals Late-Onset Sepsis Length of hospital stay Long-Term outcomes Necrotizing Entercolitis (NEC) Product Retinopathy of Prematurity (ROP)
Prolacta Bioscience appoints David Steinberg as chief financial officer
Type: Press Releases
Topic(s): Company
International Conference on Human Milk Science & Innovation to discuss latest research on bioactivity and neurodevelopment
Type: Press Releases
Topic(s): Clinical Studies Conferences and Events Neurodevelopmental Outcomes Probiotics
Prolacta Bioscience salutes World Human Milk Donation Day, thanks donors who save fragile infant lives every day
Type: Press Releases
Topic(s): Donors
Study published in the journal Cell Host & Microbe offers proof of concept that a human milk-based synbiotic could allow therapeutic manipulation of the gut microbiome
Type: Press Releases
Topic(s): Clinical Studies Company Microbiome
Alecia-Jane Twigger, Ph.D., wins the Ruth A. Lawrence Investigator Award for outstanding contributions to advancing human milk science
Type: Press Releases
Topic(s): Clinical Studies Conferences and Events
Independent, head-to-head study shows significant health benefits of early fortification associated with Prolacta Bioscience’s 100% human milk-based fortifiers compared to cow milk-based fortifiers for premature infants
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Early Fortification
